Pakistan begins last anti-polio vaccination campaign of the year after a surge in cases

Published Date: 18 Dec 2024

Pakistan on Monday began its last nationwide vaccination campaign for the year to protect 45 million children from polio after a surge in new cases hampered efforts to stop the disease, officials said.

Read Full News

Latest News

1 in 5 Pregnancies Not Screened for Syphilis on Time

One fifth of pregnant women are not being screened in a timely manner for syphilis, according to a new study in Ontario.

Hospital Ownership Status Affects Pulmonary Outcomes

New study shows private equity acquisition linked to worse outcomes for patients with pneumonia and COPD.

Experts on AxSpA-IBD Treatment Weigh In on NSAIDs, Biologics

Experts offer treatment tips for patients with axial spondyloarthritis who also have inflammatory bowel disease.

Is Rheumatology Entering the Multiomics Era?

Experts say biomarker research and multiomics are pushing rheumatology toward more individualized treatment strategies and earlier disease classification.

US Doctor in Contact With Ebola Patient Heading to Czech Hospital From Uganda

A U.S. doctor will be transferred from Uganda to a hospital in Prague on Wednesday after he ⁠came into contact with a patient infected with Ebola, Czech health officials...

Ebola Likely Circulating in Congo for Two Months, Outbreak to Grow, WHO Says

The Ebola outbreak linked to more than 130 deaths in eastern Democratic Republic of Congo likely started two months ago and is expected to continue to grow, the World Health...

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

One fifth of pregnant women are not being screened in a timely manner for syphilis, according to a new study in Ontario.

New study shows private equity acquisition linked to worse outcomes for patients with pneumonia and COPD.

Experts offer treatment tips for patients with axial spondyloarthritis who also have inflammatory bowel disease.

Experts say biomarker research and multiomics are pushing rheumatology toward more individualized treatment strategies and earlier disease classification.

A U.S. doctor will be transferred from Uganda to a hospital in Prague on Wednesday after he ⁠came into contact with a patient infected with Ebola, Czech health officials...

The Ebola outbreak linked to more than 130 deaths in eastern Democratic Republic of Congo likely started two months ago and is expected to continue to grow, the World Health...

News All Time

CDC Aiding Withdrawal of Affected Americans After Ebola Outbreak in Congo, Uganda

The U.S. Centers for Disease Control and Prevention said on Sunday it mobilized response efforts following an ⁠Ebola outbreak in the Democratic Republic of Congo and Uganda,...

Hantavirus Ship in Rotterdam to Be Disinfected, Crew Quarantined

The luxury polar explorer docked at the Dutch port of Rotterdam, where ⁠authorities were quarantining the last 27 people to disembark and planned to cremate a German who died.

Amgen Rare Disease Drug Linked to Deaths, Liver Injuries in Japan

About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's ⁠rare disease drug Tavneos.

Women With Lupus Face Troubles in Second Pregnancies

Women with systemic lupus erythematosus are less likely to have a second delivery and more likely to experience recurrent pregnancy complications, especially preterm birth.

FDA Approves First Golimumab Biosimilars to Treat RA and UC

The biosimilar approvals do not include Simponi and Simponi Aria’s indications outside of rheumatoid arthritis and ulcerative colitis.

Seasonal COVID Vaccine Linked With Halved Infection Risk

The COVID seasonal vaccine for 2025/2026 protects patients not only from the target strain but also from other SARS-CoV-2 variants.

NYC ‘Mold Busters’ Project Linked to Fewer ED Asthma Visits

The program is associated with improved asthma management among residents of public housing citywide, although success varies by building age, size, and other factors.

Analysis-Hantavirus Outbreak Tests Post-COVID Health Communications Playbook

A rodent-borne virus with a scary name. A mid-ocean cruise ship in quarantine. Several people dead and more falling sick.

Debate: Fast or Slow Correction of Chronic Hyponatremia?

Guidelines advise slow serum sodium correction to avoid osmotic demyelination, but recent data suggest that risk is low, and rapid correction may produce better outcomes.

Combo Therapy Tied to Better Quality of Life in Rhinitis

In patients with allergic rhinitis, fixed combinations of intranasal antihistamines and corticosteroids are tied to better quality-of-life outcomes than oral or intranasal antihistamines alone.

Novel IL-17A Inhibitor Shows Efficacy in Axial SpA

Compared with placebo, vunakizumab 120 mg significantly improves signs and symptoms of radiographic axial spondyloarthritis at week 16, with sustained efficacy through week 32.

NICE Backs First Immunotherapy for Resectable Gastric Cancer

NICE has recommended durvalumab for NHS use in England as part of perioperative treatment for adults with resectable gastric or gastro-oesophageal junction adenocarcinoma.

Idiopathic Acute Pancreatitis: Are Hidden Causes Missed?

Researchers note that microlithiasis and biliary sludge are common causes of presumed idiopathic pancreatitis, which standard ultrasound often fails to detect.

Pinpoint Giant Cell Arteritis in Primary Care

New treatments for giant cell arteritis offer steroid-free remission but require primary care clinicians to monitor for serious cardiovascular and infection risks.

Hantavirus Risk to US Public Remains Low, CDC Says

The risk from hantavirus to the general public remains very low, ⁠and the U.S. Centers for Disease Control and Prevention has more than 100 staff members actively working on...

Chronic Cough Tied to Greater Healthcare Burden

Unexplained or refractory chronic cough affects a small fraction of individuals but is associated with impaired health status, a higher number of medical visits, and higher healthcare costs.

Recommended News For You

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

For older LBCL patients, Axi-Cel exhibits durable responses and extends overall survival.

A study on lung cancer provides additional proof of the value of screening.

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

Recommended Articles For You

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer 

Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers 

A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis 

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

3.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

4.

Mapping lifelong chronic health risks for childhood cancer survivors

5.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

1.

Respiratory Ramifications of Systemic Disease: A Comprehensive Review

2.

Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery

3.

Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review

4.

Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support

5.

Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

2.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

3.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot